Signal active
Organization
Contact Information
Overview
GeneQuantum Healthcare (Suzhou) Co., Ltd. is a high-tech company that focuses on the research and development of innovative Bio-therapeutics.
GeneQuantum was founded in August 2013 at Suzhou Industrial Park, and has built-up a world-class bio-conjugation technology platform, focusing on developing series of next generation anti-tumor Antibody-Drug-Conjugates (ADCs) with best-in-class potential. Securing this round of financing will significantly promote the development of current ADC candidates towards IND filling in both US and China, meanwhile further expanding the company's product pipeline.
About
Health Care, Personal Health, Therapeutics
2013
51-100
Headquarters locations
Asia
Social
N/A
Profile Resume
GeneQuantum Healthcare headquartered in Asia, operates in the Health Care, Personal Health, Therapeutics sector. The company focuses on Health Care and has secured $740.8M in funding across 36 round(s). With a team of 51-100 employees, GeneQuantum Healthcare is actively contributing to advancements in Health Care. Their latest funding round, Series A - GeneQuantum Healthcare, raised $5.8M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
3
2
0
$20.6M
Details
3
GeneQuantum Healthcare has raised a total of $20.6M in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2019 | Early Stage Venture | 14.8M | ||
2021 | Late Stage Venture | |||
2017 | Early Stage Venture | 5.8M |
Investors
GeneQuantum Healthcare is funded by 16 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
GeneQuantum Healthcare | - | FUNDING ROUND - GeneQuantum Healthcare | undefined |
TF Capital | - | FUNDING ROUND - TF Capital | 5.8M |
GeneQuantum Healthcare | - | FUNDING ROUND - GeneQuantum Healthcare | 5.8M |
Oriza Seed Capital (Oriza Yuandian) | - | FUNDING ROUND - Oriza Seed Capital (Oriza Yuandian) | 5.8M |
Recent Activity
There is no recent news or activity for this profile.